Does irbesartan prevent the progression of nephropathy in patients with nephropathy due to type 2 diabetes?
Patients with nephropathy due to type 2 diabetes
Irbesartan (angiotensin-II-receptor blocker)
Progression of nephropathy
Irbesartan provides renoprotection against the progression of diabetic nephropathy independent of its blood pressure-lowering effects.
The angiotensin-II-receptor blocker irbesartan is effective in protecting against the progression of nephropathy due to type 2 diabetes. This protection is independent of the reduction in blood pressure it causes.
Building similarity graph...
Analyzing shared references across papers
Loading...
Edmund J. Lewis
Lawrence G. Hunsicker
William R. Clarke
New England Journal of Medicine
Vanderbilt University
University of Iowa
University of Colorado Denver
Building similarity graph...
Analyzing shared references across papers
Loading...
Lewis et al. (Thu,) studied this question.
www.synapsesocial.com/papers/69d56c3f75589c71d767cd2f — DOI: https://doi.org/10.1056/nejmoa011303